Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-Articular Autologous Bone Marrow Aspirate vs Placebo Injection and Lipoaspirate Micronized With Leukocyte-Poor Platelet Rich Plasma vs Placebo Injection Evaluations for Treatment of Knee OsteoArthritis: The ABLE OA Double-Blinded Randomized Clinical Trial

NCT05517434 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05517434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05517434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-Articular Autologous Bone Marrow Aspirate vs Placebo Injection and Lipoaspirate Micronized With Leukocyte-Poor Platelet Rich Plasma vs Placebo Injection Evaluations for Treatment of Knee OsteoArthritis: The ABLE OA Double-Blinded Randomized Clinical Trial
Lead sponsor
University Health Network, Toronto
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2028
Enrollment
148 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee